Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development.
Floris A, Mugheddu C, Sichi L, Anedda J, Frau A, Sorgia J, Volsi LL, Paladino MT, Congia M, Chessa E, Angioni MM, Naitza M, Ferreli C, Piga M, Atzori L, Cauli A. Floris A, et al. Among authors: atzori l. Rheumatology (Oxford). 2024 May 23:keae257. doi: 10.1093/rheumatology/keae257. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38781521
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E. Russo F, et al. Among authors: atzori l. Clin Cosmet Investig Dermatol. 2023 Dec 12;16:3561-3574. doi: 10.2147/CCID.S416149. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38107670 Free PMC article.
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
Fargnoli MC, Antonetti P, Atzori L, Taddeucci P, Di Stefani A, Grandi V, Lospalluti L, Lacarrubba F, Vaccari S, Amerio P, Fabbrocini G, Rossi M, Campione E, Caposiena Caro RD, Moscarella E, Rongioletti F, Pellegrini C, Peris K, Discab. Fargnoli MC, et al. Among authors: atzori l. Dermatology. 2023;239(3):387-392. doi: 10.1159/000529368. Epub 2023 Feb 8. Dermatology. 2023. PMID: 36754039
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: atzori l. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
[Sexually transmitted infections: a new hub&spoke model to control the increasing trend of STIs in Italy and prevent their spread].
Suligoi B, Aiello A, Atzori L, Bordonaro P, Capra G, Caraglia A, Cellini A, Chessa M, Comar M, Cusini M, Dal Conte I, Fasciana T, Galano A, Giammanco A, Lucchini A, Rossolini GM, Salfa MC, Vaggelli G, Palamara AT. Suligoi B, et al. Among authors: atzori l. Epidemiol Prev. 2024 Nov-Dec;48(6):456-465. doi: 10.19191/EP24.6.A764.136. Epidemiol Prev. 2024. PMID: 39679486 Free article. Italian.
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.
Malagoli P, Dapavo P, Amerio P, Atzori L, Balato A, Bardazzi F, Bianchi L, Cattaneo A, Chiricozzi A, Congedo M, Fargnoli MC, Giofrè C, Gisondi P, Guarneri C, Lembo S, Loconsole F, Mazzocchetti G, Mercuri SR, Morrone P, Offidani AM, Palazzo G, Parodi A, Pellacani G, Piaserico S, Potenza C, Prignano F, Romanelli M, Savoia P, Stingeni L, Travaglini M, Trovato E, Venturini M, Zichichi L, Costanzo A. Malagoli P, et al. Among authors: atzori l. Dermatol Ther (Heidelb). 2024 Oct;14(10):2739-2757. doi: 10.1007/s13555-024-01255-4. Epub 2024 Sep 24. Dermatol Ther (Heidelb). 2024. PMID: 39316358 Free PMC article. Review.
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE.
Bernardini N, Skroza N, Atzori L, Mugheddu C, Megna M, Cacciapuoti S, Ortoncelli M, Montesu MA, Carpentieri A, Carriero M, Atzori MG, Addis G, Balestri R, Rech G, Bruni P, Papini M, Potenza C. Bernardini N, et al. Among authors: atzori l. Drugs Context. 2024 Sep 5;13:2024-6-3. doi: 10.7573/dic.2024-6-3. eCollection 2024. Drugs Context. 2024. PMID: 39263599 Free PMC article.
Biologic anti-IL17 drugs in erythrodermic psoriasis.
Falco A, Mugheddu C, Anedda J, Pizzatti L, Tatti A, Conti B, Atzori L. Falco A, et al. Among authors: atzori l. JAAD Int. 2024 Jun 22;16:257-263. doi: 10.1016/j.jdin.2024.05.007. eCollection 2024 Sep. JAAD Int. 2024. PMID: 39253694 Free PMC article.
330 results